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Abstract 
  
Background: Autism spectrum disorder (ASD) is a complex neurodevelopmental 
disorder with multiple genetic and environmental risk factors. The interplay between 
genetic and environmental factors has become the subject of intensified research in 
the last several years. Vitamin D deficiency has recently been proposed as a possible 
environmental risk factor for ASD. 
Objective: The aim of the current paper is to review the research regarding the 
possible connection between ASD and vitamin D, and to address the issue of how 
vitamin D might be involved in the etiology or phenotypical expression of autism.  
Results: Systematic data obtained by different research groups provide some support 
the possible role of vitamin D deficiency in the pathogenesis of ASD. There are two 
main areas of involvement of vitamin D in the human body, that may have direct 
impact on the development of ASD: (1) brain homeostasis, brain’s own immune 
system and neurodevelopment, and (2) gene regulation. 
Conclusion: Vitamin D deficiency – either during pregnancy or early childhood – 
may be an environmental trigger for ASD in individuals genetically predisposed for 
the broad phenotype of autism. On the basis of the results of the present review, we 
argue for the recognition of this possibly important role of vitamin D in ASD, and for 
urgent research in the field. 
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INTRODUCTION 
  
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with 
multiple genetic and environmental risk factors (Cannell 2010, Coleman and Gillberg 
2011). Gene-environment interaction has recently become the focus of intensified 
ASD research (Freitag et al. 2010).  
Among several established/proposed epidemiological influences on the development 
of ASD are the (a) much higher monozygotic (60-90%) than dizygotic (0-10%) twin 
concordance rates (Muhle 2004, Lichtenstein et al 2010); (b) large variability of 
phenotypic expression (even among monozygotic twins) (Lundström et al 2012), (c) 
distinct gender ratio (2-4 males to 1 female) (Nygren et al 2011); (d) relationship 
between autism and immune dysfunction (Coleman and Gillberg 2011); and (e) much 
increased rate of ASD among dark skinned children living at Northern latitudes 
(Cannell 2008, Goodman and Richards 1995; Gillberg 1995; Barnevik Olsson et al. 
2008, 2010; Eyles 2010, Keen et al. 2010).  
There is no agreement as to whether ASD prevalence is genuinely on the rise or if a 
higher reported rate in recent years might be secondary to better awareness, changing 
diagnostic trends and more sensitive diagnostic system (Coleman and Gillberg 2011). 
However, what is clear, is that the synergistic impact of neurotoxins has been steadily 
rising, either in the form of the industrial waste polluting soil, rivers and oceans, or in 
the form of additives in our food or materials of everyday life (Grandjean 2006 
Lancet). Also, vitamin D deficiency has become common due to the increasingly 
urbanized lifestyle, rising rates of obesity, and recommendations to avoid sun 
exposure promulgated from the 1980s onwards (Holick 2005; Cannell 2006; 
Schwalfenberg 2007; Bosomworth 2011). Moreover, at northern latitudes, sunlight 
with the ultraviolet B fraction is available only during a limited period of the summer. 
Dark skinned individuals require about 5 to 10 times longer exposure to sunlight to 
produce vitamin D compared to fair skinned individuals (Clemens et al. 1982). 
Therefore, when moving to northern countries, those with dark skin run the risk of not 
reaching satisfactory vitamin D levels.  
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The “group of vitamins D” have a unique role in brain homeostasis, embryogenesis 
and neurodevelopment, immunological modulation, including the brain´s own 
immune system, ageing, and also, importantly, in gene regulation (Sigmundsdottir 
2011, Ramagopalan et al. 2010, Harms et al. 2011). In addition to this effect, vitamin 
D is now believed to be involved in numerous other functions in the organism. To 
date, it has been shown to bind with more than 2,700 genes and to regulate the 
expression of more than 200 of them. Vitamin D is also known to be involved in 
healing processes (by reducing the risk of cells becoming malignant (Sigmundsdottir 
2011). 
Vitamin D deficiency – either during pregnancy or early childhood – has recently 
been proposed as a possible environmental risk factor for ASD (Cannell JJ 2008, 
Grant and Soles 2009). 
Vitamin D: definition, biosynthesis and role in metabolism?  
Vitamin D is not really a vitamin. By definition, vitamins are substances that are 
essential for body functioning but not produced by the body itself, meaning that they 
have to be obtained from exogeneous sources. Vitamin D does not fall into this 
category and should be rather viewed as a powerful steroid hormone,* since it is 
produced in the body by a cascade of chemical transformations, commencing with a 
key photochemical reaction in the skin on exposure to the ultraviolet rays of the sun, 
followed by a series of further chemical transformations. Its receptors have been 
found in many tissues and organs. Its best known role is to facilitate the calcium and 
phosphate absorption in the intestine, impacting directly on the formation of the bones 
and their density. The biosynthesis of calcitriol, the active form of vitamin D of 
vertebrates, starts from its prime precursor 7-dehydrocholesterol, which in turn is 
produced by a complex cascade from acetyl coenzyme A via mevalonic acid, farnesyl 
pyrophosphate, squalene, and lanosterol, and is eventually hydrogenated to produce 
cholesterol. 7-dehydrocholesterol first undergoes the key photochemical 
electrocyclization reaction in the skin, producing an intermediate that is spontaneously 
converted into calciferol (vitamin D3), or cholecalciferol to be precise and to 
emphasize its chemical relation to cholesterol. Since the first reaction requires 
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irradiation with UV light (at 290-315 nm), it can only proceed in the skin, i.e., within 
the reach of the UV rays. Cholecalciferol is then transported to the liver, where it is 
hydroxylated in the side-chain (at position 25) by the microsomal enzyme 25-
hydroxylase to produce calcidiol [25(OH)D, or cholecalcidiol]. Finally, the latter 
compound is further transported to the proximal tubules of the kidneys, where it is 
further hydroxylated (at position 1α) by the enzyme 1α-hydroxylase to finally produce 
calcitriol [i.e., 1,25-dihydroxycalciferol, 1,25(OH)2D, or cholecalcitriol], the active 
compound (vitamin D1). The levels of the enzyme required for the final hydroxylation 
are controlled by parathyroid hormone, whose secretion is, in turn, triggered by low 
concentrations of calcium or phosphate. The latter enzymatic hydroxylation reaction, 
producing calcitriol, has also been found to occur in lymphocytes. 
For the sake of simplicity and to avoid confusion, which is widespread in the 
literature, we will use the following nomenclature for the vitamin D family originating 
from 7-dehydrocholesterol: calciferol for cholecalciferol (vitamin D3), calcidiol for 
25-hydroxy-cholecaciferol (vitamin D2), and calcitriol for 1,25-dihydroxy-
cholecalciferol (vitamin D1). Where the literature does not discriminate, we will refer 
to vitamin D in general. Analogues originating from ergosterol would then be 
specifically highlighted as ergocaciferol, etc.  
Vitamin D in the body follows first-order mass action kinetics (Holick 2005), which 
means that at serum levels lower than 50 nmol/L the majority of ingested or sun-
derived vitamin D is immediately diverted to metabolic needs leaving nothing to its 
higher functions within the brain, immune system, or gene regulation. 
Estrogens have the ability to increase the levels of calcitriol while testosterone does 
not. Vitamin D deficiency during gestation has been linked with dysregulation of 
many proteins involved in brain development. Thus, rat pups developed increased 
brain size and enlarged ventricles – both abnormalities reported in a minority of 
autism cases (Cannell 2008; Lainhart et al. 2006). Calcitriol also has the capacity to 
down-regulate inflammatory cytokines, which, according to a few  studies, have been 
found to be elevated in children with autism (Singh 1997; 2002). Some families of 
children with autism have also been reported to experience clusters of autoimmune 
disorders (Atladóttir et al. 2009). 
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 Deficiency in calcitriol may stem from the inherited polymorphisms in cytochrome 
P450 gene CYP27B1, which is required for the hydroxylation of calcidiol (Cannell 
2008).  
There are two main areas of involvement of vitamin D in the human body, which may 
have direct impact on the development of ASD: (1) brain homeostasis, brain’s own 
immune system and neurodevelopment, and (2) gene regulation. 
The aim of the current paper is to review research findings regarding the connection 
between ASD and vitamin D. 
  
METHODS 
A literature search covering the period January 1 1995 through October 31 2011  was 
made in PubMed, the Web of Knowledge, EBSCO OVID, MEDLINE, 
PsycARTICLES, Psychology and Behavioral Sciences Collection, PsycINFO, 
SocINDEX databases with Full Text Number of Hits.  
The search strategy was as follows: vitamin d or vitamin D or ergocalciferol or 
vitamin d2 or vitamin D2 or vitamin d 2 or vitamin D 2 or cholecalciferol or vitamin 
d3  or vitamin D3 or vitamin d 3 or vitamin D 3 or calcitriol or vitamin 1,25 D3 or 
vitamin 1,25 d3 or vitamin 1,25 D 3 or vitamin 1,25 d 3 or calcidiol or vitamin 25 D 
or vitamin 25D or 25 hydroxy vitamin d or 25-OHD or 25- hydroxyvitamin D or 25 
hydroxyvitamin D or 25 hydroxy vitamin d or 25 hydroxyvitamin D AND autism or 
autism spectrum disorder or ASD or Asperger. 
 
 
 
 
RESULTS 
A systematic literature search yielded 35 articles from PubMed that dealt with autism 
and vitamin D in one way or another.  Only four studies have looked at vitamin D 
serum levels in individuals with diagnosed ASD.  
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The search was then supplemented by articles reporting on vitamin D and its 
relationship to brain function.  
 
Results were grouped under seven subheadings, relating to different aspects of 
vitamin D and autism: (1) D-vitamin in individuals with autism, (2) Genetics and gene 
regulation, (3) Brain homeostasis, neurodevelopment and brain’s own immune 
system, (4) Epilepsy/seizures, (5) Medication during pregnancy, (6) Nutritional status 
during pregnancy and early childhood,  and (7) Latitudinal effects and ethnicity. 
 
1) Autism – vitamin D: research studies documenting vitamin D-levels in 
individuals with autism and their family members HERE YOU MUST PUT 
a brief table with the few studies that have ever looked at actual vitamin D-
levels in autism and describe and conclude on the basis of that table in a 
brief text section! 
2)  Autism – vitamin D: genetics and gene regulation 
Previous genetic findings in ASD indicated that the likely causes of ASD involve 
mutations or common variants in genes, which are involved in (1) cell-cell interaction 
and synaptic function, including development of dendritic spines, (2) neuronal 
migration and growth, or (3) excitatory and inhibitory neurotransmission (Freitag*). 
Animal research has demonstrated that Vitamin D plays a role, to some extent, in all 
of these brain processes  (Eyles el at. 2011)  
 
Vitamin D exerts its effects on genes through the vitamin D receptor (VDR), which 
binds to specific locations of the genome to influence gene expression. Employing the 
ChIP-seq technique, Ramagopalan et al (2010) isolated fragments of genomic DNA 
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bound to the VDR before and after treatment of cells with calcitriol, and then 
sequenced the DNA fragments. By mapping the sequences back to the genome, the 
group identified more than 2,700 sites of VDR binding, a number showing the 
importance of vitamin D in human body and also the wide variety of biological 
pathways in which vitamin D plays a role in. These findings support the hypothesis 
that vitamin D interacts with genes in the pathogenesis of diseases and underscores 
the serious risks of vitamin D deficiency (Ramagopalan SV 2010; Kalueff 2006).  
 
Prenatal vitamin D deficiency or defects in its metabolism can disrupt normal neuro-
development as vitamin D plays a role in neuronal growth (Ciu et al. 2007) and in 
regulating cell proliferation in the developing brain. This role is corroborated by 
detecting calcitriol and its receptors in a variety of brain tissues early in 
embryogenesis (McGrath et al. 2001). 
 
Recent studies portray the role of signalling pathways in the brain and the synapse 
structure as crucial to the development of ASD. Most plausible explanations consider 
an interplay between underlying genetic and biological factors. The importance of this 
hypothesis is that risk factors for autism involve a combination of genetic 
susceptibilities and environmental exposures. Interestingly, cytogenetic aberrations in 
autistic individuals have been located in nearly every chromosome (Gillberg 1998).  
 
3) Autism – vitamin D: neurodevelopment, brain homeostasis and the brain’s own 
immune system 
Table I provides an overview of some of the most important papers published in 
recent years on the role of vitamin D for brain development and brain functions. 
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In view of the presence of the vitamin D system, its activating enzymes, and vitamin 
D receptors (VDR) in the brain, and assuming that they are involved in normal brain 
functioning, an argument can be made for re-classifying the vitamin D group as 
neuro-steroids. In addition, the presence of high levels of VDR in the developing 
brain from very early stages and its increase with gestational age, suggests a role for 
vitamin D in neurodevelopment. It seems reasonable to speculate that vitamin D 
deficiency during development could be a risk-modifying factor in relation to other 
factors, such as maternal infection, stress, or neurotoxicity (Cannell 2008; Grant 
2009; Bodnar 2007). 
 
Various animal studies have demonstrated the role of Vitamin D in mammalian brain 
development.  For example in the down-regulation of neurologically harmful 
cytokines in rat?? brain (Moore et al. 2005), is it this reference about age-related 
inflammatory changes in the rat hippocampus? If so, maybe it is not needed here./ef  
the partial reversal of brain damage in rats (Burne et al. 2004), and to increase cellular 
levels of glutathione (Garcion et al. 2002), which is capable of removing free radicals 
and to chelate heavy metals, including mercury (Kern et al. 2006).  Vitamin D also 
plays a trophic role in the central nervous system (CNS) and also protects cultured 
cortical neurons from glutamate excitotoxicity via up regulation of the VDR 
(Blaylock 2009).  In children with autism, Vitamin D deficiency has been shown to 
dysregulate 36 proteins involved in brain development (Almeras 2007). Maybe this 
paragraph is a bit too far from autism?/ef THIS IS NOT AT ALL WHAT THE 
ALMERAS PAPER SHOWS – INSTEAD THEIR PAPER IS ALL ABOUT ADULT 
RATS!!! I WONDER IF THIS WHOLE SECTION SHOULD BE DELETED OR AT 
LEAST REPHRASED IN A MAJOR WAY. THE OVERENTHUSIASTIC TONE IS 
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STILL PERVASIVE IN THIS NEW VERSION, AND ALL THE CLAIMS HAVE 
TO BE TONED DOWN. SEVERAL OF THE REFERENCES THAT I HAVE 
LOOKED AT DO NOT AT ALL SUPPORT THE VERY STRONG CLAIMS 
BEING MADE IN THIS TEXT. 
 
Many studies show that vitamin D plays a major role in brain homeostasis. For 
example, Taniura et al. (2006) has demonstrated a very high level of activity of the 
vitamin D specific DNA-response element (VDRE) in the cerebellum, a brain region 
that has been frequently linked to autism and also other neurodevelopmental 
disorders. Other areas of the brain, e.g hippocampus, limbic system, pituitary, 
substantia nigra, white matter, diencephalon and cerebral cortex also have higher 
concentrations of VDR and the enzyme necessary for conversion of calcitriol (Eyles 
2005).. 
 
Vitamin D affects numerous cellular functions and animal studies have demonstratred 
a specific rol in cell differentiation, neurotrophic factor expression, cytokine 
regulation, neurotransmitter synthesis, intracellular calcium signalling, anti-oxidant 
activity, and the expression of genes and proteins involved in neuronal differentiation, 
structure and metabolism (Eyles 2011). 
   
Animal studies showed that Vitamin D deficiency has a negative effect on embryonic 
neurodevelopment, manifested, e.g., in decreased neurotrophic factor levels, increased 
mitosis, and decreased apoptosis, enhanced proliferation, and some changes in the 
brain morphology and altered behaviour (Eyles et al 2006; Harms et al 2011). It is 
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known that microglia contain vitamin D receptors (VDR) and when they are activated, 
they can actually synthesise calcitriol (Neveu et al. 1994; Lefebvre et al. 2003).  
A very high activity was observed for vitamin D specific DNA-response element 
(VDRE) binding in the cerebellum of a rat (Taniura 2006). In human brain, there are 
higher concentrations of VDR in the cerebellum, hippocampus, limbic system, 
pituitary, substantia nigra, white matter diencephalon, and cerebral cortex, as well as 
of the enzyme 1α-hydroxylase (encoded by the CYP27B1 gene), which is essential for 
the synthesis of the active form, i.e., calcitriol (Eyles 2005). 
 
In addition, calciferol induces the production of anti-inflammatory cytokines IL-10, 
IL-4 and TGF-β1. Its deficiency has been shown to suppress NOS has NOS been 
explained? and to result in elevation of glutathione levels. Furthermore, calciferol 
significantly stimulates the production of glial-derived neurotropic factor (GDNF) and 
thus serves as a neuroprotective agent (Cantorna MT 1996). 
 
 
3) Autism – vitamin D and epilepsy/seizures 
Animal and clinical studies have demonstrated the neuroprotective role of vitamin D 
in epilepsy, multiple sclerosis, Parkinson’s disease, and chronic stress. As epilepsy 
and convulsions are common in autism, it is most interesting to note calcitriol’s 
neuroprotective effects via its inhibitory effect on Ca2+ influx. Calcitriol up-regulates 
the expression of the Ca2+-binding proteins calbindin and parvalbumin in motor 
neurons (Alexianu 1998), which chelate intracellular Ca2+ and thus limit the 
excitotoxicity (Harms 2011). 
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Vitamin D deficiency thus might lead to disruption in calcium signalling and 
homeostasis, which might account for some pathologies and disrupted information 
processing typical for autism. Severe vitamin D deficiency (calcidiol) has been shown 
to be associated with seizures caused by disruption of calcium levels (Mehrotra 2009). 
Vitamin D has also been shown to increase the electroconvulsive threshold for 
seizures, to decrease the severity of seizures, and to enhance the effect of the 
antiepileptic medication (Siegel 1984; Kalueff 2005; Borowicz 2007). The protection 
against excitotoxicity might also explain the protective action of vitamin D against 
seizures (Harms 2011).  
However, antiepileptic drugs are known to decrease vitamin D levels, which further 
complicate research of the potential link between vitamin D deficiency and increased 
risk of seizures (Bergquist 2007). 
 
4) Autism – vitamin D and medication during pregnancy 
Bromley et al. (2009) reported on an increased incidence of autism among infants of 
mothers taking antiepileptic medication, especially sodium valproate, during 
pregnancy. This finding may suggest low vitamin D levels as a possible mechanism 
deserving further investigation. An inverse relationship between the antiepileptic 
drugs and 25-hydroxyvitamin D levels have been (Borowicz et al. 2007) demonstrated 
in animal research.  
 
5) Autism – vitamin D and nutritional status  
One of the suggested mediating roles of vitamin D in aetiology of autism is its 
involvement in absorption of magnesium (Mg) (Johnson 2000), one of several very 
important micronutrients, known for several crucial roles in brain development, e.g., 
13 
 
preventing oxidative damage. The absorption of magnesium requires adequate levels 
of parathyroid hormone and vitamin D and may thus be dependent on nutrition as well 
as season and sun exposure. There are many studies examining a possible relationship 
between month and season of birth and risk for autism spectrum disorders. However, 
results are diverging as to potential risk period and some have found no support at all 
for a seasonality hypothesis (Gillberg 1990, Landau et al. 1999, Kolevzon  et al. 2006, 
Hebert et al. 2010, Zerbo et al. 2011).  
 
It has been suggested that supplementation with zinc, magnesium, ascorbic acid and 
the vitamins necessary for magnesium metabolism, namely vitamin D and B6, started 
before pregnancy, may prevent some cases of autism, schizophrenia, epilepsy and 
Parkinson’s disease (Johnson 2000, 2011?).   which year for the reference?/ef 
Is this the reference? Johnson DD, Wagner CL, Hulsey TC, McNeil RB, Ebeling M, 
Hollis BW. Vitamin D deficiency and insufficiency is common during pregnancy. Am 
J Perinatol 2011;28(1):7-12.  
Lindsay et al. (2006) used a quantitative Food Frequency Questionnaire (FFQ) to 
prospectively study the nutritional intake of 20 children (5-13 years old) with autism. 
The results of this questionnaire study suggested that fifty percent of these children 
with autism were likely to have inadequate vitamin D intake. 
 
Several observational and clinical studies reported vitamin D deficiency in children 
with autism as a consequence of their highly selective nutritional intake. Individuals 
with autism have been reported very often to have selective nutritional manners, 
which can potentially exacerbate their vitamin D deficiency/insufficiency status.  
Several studies reported an association between the vitamin D status and nutrition in 
children or young people with autism. Thus, Shamberger (2010) in an ecological  
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study across the 50 United States, showed that infants who were solely breast-fed had 
diets low in Vitamin D and other nutrients and that in States with high rates of 
exclusive breast-feeding, autism rates were also higher.  This implies the need for 
vitamin supplementation during lactation period as nutrition may be important in the 
development of autism. 
 
Herndon et al. (2008) found few differences in average nutritional intake between 
children with autism and typically developing children in Colorado, USA. However, a 
large proportion of children in both groups did not meet the national 
recommendations for daily intake of fibre, calcium, iron, vitamin E and vitamin D. 
Very similar results have been reported recently by Sadowska J and Cierebiej M 
(2011) in Poland.  
 
There are 4 case studies reporting an extreme form of the inadequate nutritional status 
due to the selectivity with food and food avoidant-behaviours in children or young 
people with autism, leading to the symptomatic nutritional rickets or painful leg 
weakness. In all cases a severe vitamin D deficiency was diagnosed and then 
successfully treated with adequate diet and vitamin D supplementation (Noble et al 
2006; Weig SG 2009; Stewart C and Latif A 2007; Clark JH 1993). This reflects 
high rates of acquired hypo-calcemia and hypo-vitaminosis D in subgroups of 
children and adolescents with autism and suggests the importance of comprehensive 
history-taking, careful diet assessment, and when appropriate, screening for vitamin 
deficiencies as an integral part of every child with autism’s medical care (Noble et al 
2006).  
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Three studies investigated plasma levels of vitamin D in individuals with autism.  
Humble et al (2010) tested Vitamin D levels in adult outpatients with a range of 
psychiatric disorders and found that those with a diagnosis of autism or schizophrenia 
had significantly lower levels than other groups.  This study demonstrated a 
considerable improvement in several patients of some of their psychiatric 
symptoms, e.g. psychosis and depression. However, there are some limitations of 
this study as there is very little information on details of the treatment and there 
was no control group. Molloy et al. (2010) explored the comparison of the actual 
plasma 25(OH)vitamin D3 levels in a cohort of Caucasian boys with ASD diagnosis 
(4-8 years old) and a group of age-matched typically developing comparison boys 
having intravenous catheters placed for outpatient tonsillectomies. There were no 
differences observed in the levels between participants with ASD and controls, 
however the majority of all children in this cohort (61%) had low vitamin D levels 
(<20 ng/ml or <50 nmol/L). This is the minimum concentration recommended by the 
American Academy of Paediatrics to ensure adequate bone health. This supports 
major health concerns regarding the use of sun blocks, increased indoor activities with 
limited sun exposure among children and inadequate dietary sources. In addition the 
limitation of this study has to be taken into account -  
Meguid et al. (2010) reported a cohort of Egyptian children with ASD having 
significantly lower levels of both 25(OH) vitamin D3 (28.5 ng/ml) and 1,25(OH)2 
vitamin D3 (27.1 ng/ml) levels as well as lower calcium serum values compared to 
healthy controls. No significant difference was found for the month and season of 
birth among either group.  
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Although these results regarding vitamin D levels in children and adults with autism 
appear conflicting, of the three studies, two are subject to significant methodological 
problems. The Molloy study suffered from the fact that the control children were 
likely to have had some degree of inflammation, which could possibly have affected 
the vitamin D levels.  The Humble study did not have a control group and studied a 
range of disorders, not only autism.  In contrast, in the Meguid study, vitamin D was 
measured in an appropriate manner and the recruitment of cases and controls 
minimised bias.  Taking these studies together, they are suggestive that there may be 
an association between low Vitamin D and autism and this will be an important 
direction for future research. 
  
 
6) Autism – vitamin D, clinical studies; latitudinal effects and ethnicity 
Grant et al. (2009) has found a strong effective latitudinal (related to wintertime solar 
UVB radiation) increase in infantile autism prevalence. These finding are consistent 
with the hypothesis of maternal vitamin D deficiency being a risk factor for autism,..  
In 1995 Gillberg et al. (1995) reported on 3 boys with autism, born in one area of 
Sweden and with mothers coming from Uganda and discussed possible reasons for the 
high autism rate in this particular ethnic subgroup.  
Due to an increased prevalence of autism in children of Somali origin living in 
Sweden, and the evidence that low vitamin D impacts adversely on brain 
development, serum levels of 25-hydroxyvitamin D were analysed in mothers of 
Somali origin with and without a child with autism (Fernell et al. 2010).  Both groups 
of mothers of Somali origin had significantly lower values of 25-hydroxyvitamin D 
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compared to Swedish mothers. The difference in the levels of 25-hydroxyvitamin D 
between mothers of Somali origin with and without a child with autism was not 
statistically significant, but the lowest values were found in mothers with a child with 
autism. The authors concluded that the findings regarding very low vitamin D levels 
generally in Somali mothers have considerable consequences in a public health 
perspective.  
A review by Dealberto (2010) found several studies reporting increased rates of 
autism among dark-skinned immigrant mothers, especially those who moved to high 
latitudes. The results of this review are consistent with the hypothesis that the 
maternal deficiency (or insufficiency) levels of vitamin D may be associated with 
autism.  
 
Although the prevalence rates of autism in African and Arabic countries have not yet 
been clearly established, Bakare et al. (2011) in his review reports autism and 
hypomelanotic disorders (such as albinism) can co-occur. This association between 
autism and oculo-cutaneous albinism led Bakare (2011) to formulate a hypothesis of 
individuals with hypo-melanotic skin types being genetically more predisposed to 
autism with an acknowledged modulatory role of vitamin D deficiency.   Aetiological 
factors postulated included post-encephalitic infection, genetic and auto-immune 
factors, and vitamin D deficiency.  
 
A list of clinical studies of vitamin D and autism are presented in Table 2. 
                                                      DISCUSSION 
18 
 
Vitamin D deficiency – either during pregnancy or early childhood – has recently 
been proposed as a possible environmental risk factor for ASD. A large number of 
studies support the role of vitamin D in numerous cellular functions; in particular cell 
differentiation, neurotrophic factor expression, cytokine regulation, neurotransmitter 
synthesis, intracellular calcium signalling, anti-oxidant activity, to partially reverse 
brain damage (Burne et al. 2004), and to increase cellular levels of glutathione 
(Garcion et al. 2002) and the expression of genes and proteins involved in neuronal 
differentiation, structure and metabolism (Eyles 2011). Results of these studies have 
been translated into theories and hypotheses regarding a possible involvement and 
role of vitamin D in aetiology and/or phenotype expression of autism. However, most 
of these theories are still only hypotheses, some more plausible than others. Most of 
these hypotheses support the notion that neither genetic nor environmental exposure 
operate alone. Risk factors involve a combination of genetic susceptibilities and 
environmental exposures, Figure 1.   
 
Fig 1 Vitamin D role of a key modulator in a complex interplay of genetic 
predispositions and environmental factors in the aetiology of autism 
 
19 
 
 
 
Latitudinal effects, skin pigmentation and some medications play a significant role in 
pregnancy and support the hypothesis of vitamin D deficiency involvement in 
etiology of autism. There is now evidence to recommend that all pregnant women 
should be screened for vitamin D deficiency and the supplement dosage should reflect 
the needs of both mother and foetus, especially during the third trimester and 
lactation.   
Interest in ongoing research in schizophrenia might provide possible clues to the 
research of autism as there are some parallels between aetiology of both disorders and 
hypothetically both may be related to prenatal and developmental vitamin D 
deficiency (Grant et al. 2009; Humble et al. 2010).  
When children with ASD were studied as to level of vitamin D status they were 
repeatedly shown to have inadequate intake of vitamin D and other nutrients due to 
Environmen
tal Factors 
Genetic 
Predispositi
on 
Vitamin D  
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their highly selective intake of food and thus children with autism are one of the 
populations that are at a great risk of being deficient in vitamin D. Thus, patients with 
ASD should have their diet carefully assessed and, when appropriate, screened for 
vitamin deficiencies as an integral part of the child/patient’s medical care (Noble et al 
2006).  
 
CONCLUSION 
The findings obtained over the past 15 years - including in animal studies, human 
molecular, cellular and physiologic research, post-mortem brain studies, neuro-
imaging studies, and genetic studies - support the unique role of the D vitamins in 
numerous human body processes. Although a very limited literature provides only 
weak support for the hypothesis of the modulatory role of vitamin D in the aetiology 
and phenotype of autism specifically, there is an urgent need for intensified research 
in this important area. 
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Table 2    maybe this should be table 1 
Possible Vitamin D involvement in autism 
 
First author Type of study Year 
Brain 
 
Harms  
Blaylock 
Lucas 
Lawrence 
Review 
Review 
Review 
Original article 
2011 
2009 
2008 
2008 
Foetal brain development Eyles  Review 2011 
Genetics Currenti 
Ramagopalan 
Freitag 
Review 
Original article 
Review 
2010 
2010 
2009 
De novo genetic mutations  Kinney Review 2009 
Immune system Goines  Review 2010 
Autoimmunity Dow 
Carega 
Hypothesis 
Review 
2011 
2010 
Hypomelanosis Bakare  Hypothesis 2011 
 
 
 
 
 
 
 
 
Table 2. Clinical Studies of Vitamin D and Autism        
Vitamin D and Autism Author Type 
of 
study 
Year 
Strong effect of latitudinal increase on Childhood Autism prevalence Grant et al.  2009 
Vitamin D and micronutrients (Magnesium metabolism) Johnson S Clinical 
study 
2010 
Nutrition – inadequate vitamin D intake due to the selectivity with food 
 
Lindsay 
Schamberg 
Clinical 
studies 
2006 
2010 
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Herndon 
Sadowska 
 
2008 
2011 
Extreme cases of inadequate nutritional intake resulting in  
co-morbidity of autism and rickets  
Nobel et al 
Weig 
Stewart 
and Latif 
Clark 
Clinical 
studies 
2006 
2009 
2007 
 
1993 
Medication in pregnancy – antiepileptic drugs Bromley Clinical 
study 
2009 
Ethnicity 
Observed low vitamin D in Somali mothers of children with ASD 
Increased rates of ASD among dark-skinned immigrant mothers at high  
latitudes 
Fernell 
Dealberto 
Clinical 
study 
Review 
2010 
2010 
Clinical studies 
Treatment of children with verbal apraxia (65% with co-morbid ASD) 
with omega 3 acids and vitamin D- low levels of vitamin D in 57% of children 
 
Morris 
and Agin 
Clinical 
study 
 
2009 
 
Plasma levels in children with ASD 
 
Molloy 
Meguid 
Clinical 
studies 
2010 
2010 
Plasma levels of vitamin D measured in a group of adult psychiatric out-patients  
with various psychiatric illnesses – lowest levels in groups with ASD and  
schizophrenia  
Humble Clinical 
study 
2010 
    
 
 
